Targeting MASLD and MASH in the US Hispanic/Latino Population

The prevalence of MASLD and MASH among Hispanic/Latino persons in the US is a significant public health challenge. Addressing this issue requires multifaceted, culturally mindful strategies that target disparities in nutrition, physical activity, genetics, research, and social determinants of health. Clinicians should incorporate routine FIB-4 risk stratification for MASLD in Hispanic/Latino patients with cardiometabolic risk factors to enable early detection and intervention.

Corresponding Author: Sammy Saab, MD, MPH, Pfleger Liver Institute, UCLA Medical Center, 100 Medical Plaza, Ste 700, Los Angeles, CA 90095 (ssaab@mednet.ucla.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.